157 related articles for article (PubMed ID: 27911676)
1. Tolerance and Efficacy with Simultaneous Use of Two Monoclonal Antibodies for a Patient with Hypereosinophilic Syndrome and Ulcerative Colitis.
Patel B; Butterfield JH; Weiler CR; Kane SV
Monoclon Antib Immunodiagn Immunother; 2016 Dec; 35(6):300-303. PubMed ID: 27911676
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hypereosinophilic syndrome and eosinophilic dermatitis with reslizumab.
Kuruvilla M
Ann Allergy Asthma Immunol; 2018 Jun; 120(6):670-671. PubMed ID: 29496465
[No Abstract] [Full Text] [Related]
3. Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After Primary Non-response to Infliximab and Vedolizumab.
Dalal RS; Ananthakrishnan AN; Hamilton MJ; Winter RW
Dig Dis Sci; 2021 Mar; 66(3):733-737. PubMed ID: 33569666
[No Abstract] [Full Text] [Related]
4. Etrolizumab versus infliximab in the treatment of induction phase of ulcerative colitis: A systematic review and indirect comparison.
Motaghi E; Ghasemi-Pirbaluti M; Zabihi M
Pharmacol Res; 2019 Jan; 139():120-125. PubMed ID: 30395950
[TBL] [Abstract][Full Text] [Related]
5. Vedolizumab for the treatment of ulcerative colitis.
Stallmach A; Schmidt C; Teich N
Expert Rev Gastroenterol Hepatol; 2016; 10(2):165-75. PubMed ID: 26588993
[TBL] [Abstract][Full Text] [Related]
6. Combination of vedolizumab and immunomodulators in ulcerative colitis.
Pinton P
J Gastroenterol Hepatol; 2021 Dec; 36(12):3556. PubMed ID: 34519096
[No Abstract] [Full Text] [Related]
7. Should we use vedolizumab as mono or combo therapy in ulcerative colitis?
Hedin C; Halfvarson J
Best Pract Res Clin Gastroenterol; 2018; 32-33():27-34. PubMed ID: 30060935
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural evidence of mucosal healing after infliximab in patients with ulcerative colitis.
Fratila OC; Craciun C
J Gastrointestin Liver Dis; 2010 Jun; 19(2):147-53. PubMed ID: 20593047
[TBL] [Abstract][Full Text] [Related]
9. Infliximab Efficacy and Safety in an Ulcerative Colitis Patient with Systemic Lupus Erythematosus.
Ben-Horin S; Ungar B; Eliakim R; Langevitz P
J Crohns Colitis; 2016 Jun; 10(6):752-3. PubMed ID: 26826571
[No Abstract] [Full Text] [Related]
10. Using Vedolizumab to Treat Severe Sweet's Syndrome in a Patient With Ulcerative Colitis.
Belvis Jiménez M; Maldonado Pérez B; Argüelles-Arias F
J Crohns Colitis; 2018 Aug; 12(9):1134-1135. PubMed ID: 29788419
[No Abstract] [Full Text] [Related]
11. Hypereosinophilic syndrome presenting acutely with neurologic signs.
Brunet BA; Sugg RM; Stewart P
Ann Allergy Asthma Immunol; 2018 May; 120(5):461-464. PubMed ID: 29501486
[No Abstract] [Full Text] [Related]
12. Optimizing biological therapy in Crohn's disease.
Gecse KB; Végh Z; Lakatos PL
Expert Rev Gastroenterol Hepatol; 2016; 10(1):37-45. PubMed ID: 26471077
[TBL] [Abstract][Full Text] [Related]
13. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
14. Successful Vedolizumab Therapy in a Sixteen-Year-Old Boy with Refractory Ulcerative Colitis.
Zoet ID; de Boer NK; de Meij TG
J Crohns Colitis; 2016 Mar; 10(3):373-4. PubMed ID: 26574489
[No Abstract] [Full Text] [Related]
15. Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk?
Hanauer SB
Gut; 2007 Sep; 56(9):1181-3. PubMed ID: 17698862
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Mepolizumab on the Lungs in a Boy with Hypereosinophilic Syndrome.
Armoni Domany K; Shiran SI; Adir D; Lavie M; Levin D; Diamant N; Gut G; Benor S
Am J Respir Crit Care Med; 2020 Jul; 202(2):e34-e35. PubMed ID: 32150442
[No Abstract] [Full Text] [Related]
17. Nodular vasculitis during treatment with vedolizumab in a patient with ulcerative colitis.
Abbenante D; Merli Y; Misciali C; Sacchelli L; Bardazzi F
Australas J Dermatol; 2022 Feb; 63(1):131-132. PubMed ID: 34817061
[No Abstract] [Full Text] [Related]
18. Anti-TNF-A therapy about infliximab and adalimamab for the effectiveness in ulcerative colitis compared with conventional therapy: a meta-analysis.
Zhou Z; Dai C; Liu WX
Hepatogastroenterology; 2015; 62(138):309-18. PubMed ID: 25916055
[TBL] [Abstract][Full Text] [Related]
19. Intensification of maintenance therapy with infliximab in ulcerative colitis.
Casellas F
Rev Esp Enferm Dig; 2015 Sep; 107(9):525-6. PubMed ID: 26334457
[No Abstract] [Full Text] [Related]
20. Infliximab for ulcerative colitis following liver transplantation.
Lal S; Steinhart AH
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):277-80. PubMed ID: 17301656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]